Correlation Between Samsung Biologics and Sk Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Samsung Biologics and Sk Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Samsung Biologics and Sk Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Samsung Biologics Co and Sk Biopharmaceuticals Co, you can compare the effects of market volatilities on Samsung Biologics and Sk Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Samsung Biologics with a short position of Sk Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Samsung Biologics and Sk Biopharmaceutica.
Diversification Opportunities for Samsung Biologics and Sk Biopharmaceutica
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Samsung and 326030 is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Samsung Biologics Co and Sk Biopharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sk Biopharmaceuticals and Samsung Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Samsung Biologics Co are associated (or correlated) with Sk Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sk Biopharmaceuticals has no effect on the direction of Samsung Biologics i.e., Samsung Biologics and Sk Biopharmaceutica go up and down completely randomly.
Pair Corralation between Samsung Biologics and Sk Biopharmaceutica
Assuming the 90 days trading horizon Samsung Biologics Co is expected to generate 0.44 times more return on investment than Sk Biopharmaceutica. However, Samsung Biologics Co is 2.29 times less risky than Sk Biopharmaceutica. It trades about -0.25 of its potential returns per unit of risk. Sk Biopharmaceuticals Co is currently generating about -0.37 per unit of risk. If you would invest 100,000,000 in Samsung Biologics Co on August 24, 2024 and sell it today you would lose (6,600,000) from holding Samsung Biologics Co or give up 6.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Samsung Biologics Co vs. Sk Biopharmaceuticals Co
Performance |
| Timeline |
| Samsung Biologics |
| Sk Biopharmaceuticals |
Samsung Biologics and Sk Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Samsung Biologics and Sk Biopharmaceutica
The main advantage of trading using opposite Samsung Biologics and Sk Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Samsung Biologics position performs unexpectedly, Sk Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sk Biopharmaceutica will offset losses from the drop in Sk Biopharmaceutica's long position.| Samsung Biologics vs. InfoBank | Samsung Biologics vs. DataSolution | Samsung Biologics vs. Koryo Credit Information | Samsung Biologics vs. Settlebank |
| Sk Biopharmaceutica vs. Kbi Metal Co | Sk Biopharmaceutica vs. PJ Metal Co | Sk Biopharmaceutica vs. Seoul Electronics Telecom | Sk Biopharmaceutica vs. Cheryong Industrial CoLtd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |